Protective Effect of Remdesivir Against Pulmonary Fibrosis in Mice
Pulmonary fibrosis is a known sequela of severe or persistent lung damage. Existing clinical, imaging and autopsy studies have shown that the lungs exhibit a pathological pulmonary fibrosis phenotype after infection with coronaviruses, including severe acute respiratory syndrome coronavirus 2 (SARS-...
Saved in:
Main Authors: | Xiaohe Li (Author), Rui Liu (Author), Yunyao Cui (Author), Jingjing Liang (Author), Zhun Bi (Author), Shimeng Li (Author), Yang Miao (Author), Liang Zhang (Author), Xiaoping Li (Author), Honggang Zhou (Author), Cheng Yang (Author) |
---|---|
Format: | Book |
Published: |
Frontiers Media S.A.,
2021-08-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Antifibrotic Mechanism of Cinobufagin in Bleomycin-Induced Pulmonary Fibrosis in Mice
by: Xiaohe Li, et al.
Published: (2019) -
Ellagic Acid Attenuates BLM-Induced Pulmonary Fibrosis via Inhibiting Wnt Signaling Pathway
by: Xiaohe Li, et al.
Published: (2021) -
Protective Effect of Arbidol Against Pulmonary Fibrosis and Sepsis in Mice
by: Hailong Li, et al.
Published: (2021) -
Nintedanib Inhibits Wnt3a-Induced Myofibroblast Activation by Suppressing the Src/β-Catenin Pathway
by: Xiaohe Li, et al.
Published: (2020) -
IL20Rb aggravates pulmonary fibrosis through enhancing bone marrow derived profibrotic macrophage activation
by: Jingyan Zhu, et al.
Published: (2024)